Pressure-Flow Measurements Directly after Primary PCI to Predict Late Occurrence of Microvascular Obstruction

Pressure-Flow Measurements Directly after Primary PCI to Predict Late Occurrence of Microvascular Obstruction - PREDICT-MVO trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38350

Enrollment

Registered

2011-09-05

Start date

2011-12-06

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial infarction

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with acute STEMI - Presentation at catheterization laboratory within 6 hours after onset of symptoms

Exclusion criteria

Exclusion criteria: - previous myocardial infarction in the same artery - significant three-vessel disease (lesions >70%) - unsuccessful primary PCI - refusal or inability to give informed consent - contra indications for abciximab - cardiogenic shock - poor kidney function, eGFR

Design outcomes

Primary

Measure	Time frame
resistance measurements using combowire thermodilution measurements using the PressureWire Certus	—

Secondary

Measure	Time frame
MRI scan PET scan blood measurements	—

Countries

Netherlands

Outcome results